Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis.
about
Duality of lipid mediators in host response against Mycobacterium tuberculosis: good cop, bad copProgrammed necrosis in the cross talk of cell death and inflammationGranulomas and Inflammation: Host-Directed Therapies for Tuberculosis.Cell death and autophagy in tuberculosisAn outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity.What We Have Learned and What We Have Missed in Tuberculosis Pathophysiology for a New Vaccine Design: Searching for the "Pink Swan".Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes.The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NADThe role of host soluble inflammatory mediators induced by the BCG vaccine for the initiation of in vitro monocyte apoptosis in healthy Brazilian volunteersMouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.Mycobacterium bovis Induces Endoplasmic Reticulum Stress Mediated-Apoptosis by Activating IRF3 in a Murine Macrophage Cell Line.Exosomes function in antigen presentation during an in vivo Mycobacterium tuberculosis infection.Type I, II, and III Interferons: Regulating Immunity to Mycobacterium tuberculosis Infection.A potential target gene for the host-directed therapy of mycobacterial infection in murine macrophages.Prokaryotic expression and functional analysis of the Mb1514 gene in Mycobacterium bovis.Striking the right immunological balance prevents progression of tuberculosis.Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis.Mycobacterium abscessus glycopeptidolipids inhibit macrophage apoptosis and bacterial spreading by targeting mitochondrial cyclophilin D.Bcl-xL mediates RIPK3-dependent necrosis in M. tuberculosis-infected macrophages.Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditionsRestoration of innate immune activation accelerates Th1-cell priming and protection following pulmonary mycobacterial infection.Mycobacterial infection induces higher interleukin-1β and dysregulated lung inflammation in mice with defective leukocyte NADPH oxidase.The Troika Host-Pathogen-Extrinsic Factors in Tuberculosis: Modulating Inflammation and Clinical Outcomes.The patterns of in vitro cell-death and inflammatory cytokines induced by distinct BCG vaccine strains are differentially induced in human mononuclear cells.Lysosome-Mediated Plasma Membrane Repair Is Dependent on the Small GTPase Arl8b and Determines Cell Death Type in Mycobacterium tuberculosis Infection.Effect of prednisolone on inflammatory markers in pericardial tuberculosis: A pilot study.PPARγ is critical for Mycobacterium tuberculosis induction of Mcl-1 and limitation of human macrophage apoptosis.Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages.The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed TherapyProtective immune mechanisms of Yifei Tongluo, a Chinese herb formulation, in the treatment of mycobacterial infection
P2860
Q26823530-C48095D3-9A3C-44D3-8C95-4215F265B66AQ27026709-A5121CC8-87CE-485E-934F-44BD0D30D13AQ28076037-B45F1F39-13A8-46FA-B83A-FD5D9155305CQ28387214-A3CA9AA7-E700-4A7C-9FA8-FD348A2F2278Q33607137-36DBB35F-6D00-4F2C-A834-695843BBBA6CQ33679240-24197EA3-E771-4B02-BC46-CB5B42FCD2F8Q35606701-BB89F3BD-EA35-487A-BC25-103504DE67EEQ36029599-87C353B8-B99F-4F4D-9165-5F24732E6E15Q36224196-AA6C9F7E-6B7F-4720-B3C9-859AF6FFF472Q36654001-46D0426C-61CA-454B-8300-5965565B2EA8Q37492049-B6A0D9C5-D86D-4757-B550-C4A97EC61210Q37681854-5C50FCA3-1DA5-4D36-AD33-3BEED7D05792Q38585398-F8D29E0C-1AAA-4F93-A23D-D506B748C725Q38757143-E9FF4DBC-A11E-4153-B799-886AFD8C7449Q39076238-06306325-6019-4355-BD82-0A3344F9BC6CQ39437320-8EA28CE4-4480-4FFD-ABA0-51A800DED0D7Q39438318-5DB06310-A356-496B-8BA6-AB26F02F2406Q40081272-0D8B538B-0AC9-413D-9BDE-DD21C5016FB6Q40254604-50D0EAE5-F18F-4F00-A92A-3190D70A9459Q41049002-A5158243-02B1-4B64-A845-7991BDDAB5F9Q42228817-65E67802-B5CE-4FBD-88ED-946EC90D54A0Q46243855-9BF22389-33E0-4577-B4F6-353C4269865DQ47548481-14B9D237-B47E-4DFF-B1F1-8969A1BFF4C9Q47605682-87FC9371-33FA-429B-B7ED-F388C30F0B8EQ52723516-45E675A3-3132-4E70-BBEF-DCBB3FAFA787Q53683273-CE5F7A00-4744-4DE2-A8B2-109FF237807EQ55424384-3F0B5287-B8A7-4A20-A6D7-0956AE6D5610Q55453937-84A15007-CE92-407B-ABC2-4A045AF3EA8BQ58693717-8C3561E1-7458-44DA-9D65-A7675F23393AQ58752243-51FD4B3B-29DA-4AAA-A992-F26A8E45279E
P2860
Dying to live: how the death modality of the infected macrophage affects immunity to tuberculosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dying to live: how the death m ...... ects immunity to tuberculosis.
@en
type
label
Dying to live: how the death m ...... ects immunity to tuberculosis.
@en
prefLabel
Dying to live: how the death m ...... ects immunity to tuberculosis.
@en
P2860
P1476
Dying to live: how the death m ...... ects immunity to tuberculosis.
@en
P2093
Heinz Remold
Maziar Divangahi
P2860
P304
P356
10.1007/978-1-4614-6111-1_6
P407
P577
2013-01-01T00:00:00Z